Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease

Схожие документы

• A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
  по: Yoshita, M, et al.
  Опубликовано: (2001)
• Onset age and severity of motor impairment are associated with reduction of myocardial (123)I-MIBG uptake in Parkinson's disease
  по: Hamada, K, et al.
  Опубликовано: (2003)
• Diagnostic Accuracy of (123)I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
  по: Yoshita, Mitsuhiro, et al.
  Опубликовано: (2015)
• Diagnosis of dementia with Lewy bodies: can (123)I-IMP and (123)I-MIBG scintigraphy yield new core features?
  по: Sakamoto, Fumi, et al.
  Опубликовано: (2017)
• HIV Dementia with a Decreased Cardiac (123)I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies
  по: Kurihara, Masanori, et al.
  Опубликовано: (2018)